ASX AnnouncementsPAT-DX1 Engineering Run Successfully Completed4 Jul at 10:28 am0Patrys has today announced a positive update on the second engineering run for its lead asset PAT-DX1, a critical step…
NewsletterPatrys Investor Newsletter22 Jun at 4:02 pm0Our latest Investor Newsletter is here. This edition includes an update from Patrys CEO and MD, Dr James Campbell; a…
MediaPatrys on Channel 7 News20 Jun at 11:22 am0Channel 7 News Journalist Jackie Quist recently interviewed Patrys CEO and MD, Dr James Campbell, together with Telethon Kids Institute’s,…
ASX AnnouncementsPAT-DX1 Significantly Improves Survival in Animal Model of Pancreatic Cancer14 Jun at 10:06 am0Patrys has today announced the publication of new data from a series of studies by our collaborators Dr James Hansen,…
ASX AnnouncementsCure Brain Cancer Foundation Research Grant3 Jun at 3:26 pm0Patrys is pleased to share news that the Telethon Kids Institute has been awarded significant funding from the Cure Brain…
MediaMergermarket | Interview with Dr James Campbell30 May at 1:03 pm0Patrys CEO and MD, Dr James Campbell, was recently interviewed by Louise Weihart at Mergermarket, to discuss the deal potential…
MediaABC NEWS | May 20229 May at 10:05 am0Patrys CEO and Managing Director, Dr James Campbell, is presenting at the 16th Bioshares Biotech Summit to be hosted in…
ASX AnnouncementsQuarterly Activities Report and 4C28 Apr at 8:50 am0Patrys has published its Quarterly Activities Report and 4C Quarterly Cash Flow Report. Highlights for this Quarter have included: Work…
ASX AnnouncementsPatrys strengthens executive team26 Apr at 9:25 am0Patrys today announced the appointment of Dr Rebecca Tunstall to the role of Vice President, Corporate Development. As a key…
News UpdateNew research: Scientists determine structure of a DNA damage ‘First Responder’ protein23 Mar at 4:06 pm0Scientists at the Sloan Kettering Institute have debunked a 20-year guiding paradigm for how the 9-1-1 clamp – a protein…